Join
Live feed
·
NEWSReleasevia Quantisnow
IGC Pharma Inc. logo

IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia

ByQuantisnow·Wall Street's wire, on your screen.
IGC· IGC Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IGC (IGC Pharma Inc.) and more on Quantisnow.